ArticleScientific reports2024
Deep learning radiomics on grayscale ultrasound images assists in diagnosing benign and malignant of BI-RADS 4 lesions.
Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- A Systematic Review and Meta-analysis of Two-Dimensional Breast Ultrasound Radiomics: Implications for Lesion Characterization and Diagnostic Accuracy.Journal of imaging informatics in medicine · 2026Review
- Comparison of artificial intelligence (AI) services for Breast Imaging-Reporting and Data System (BI-RADS) classification on mammograms.Quantitative imaging in medicine and surgery · 2026Article
- Development and validation of an integrated model combining deep learning, radiomics, and clinical and breast ultrasound features for Breast Imaging Reporting and Data System 4A lesion malignancy classification.Quantitative imaging in medicine and surgery · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
This study aimed to explore a deep learning radiomics (DLR) model based on grayscale ultrasound images to assist radiologists in distinguishing between benign breast lesions (BBL) and malignant breast lesions (MBL). A total of 382 patients with breast lesions were included, comprising 183 benign lesions and 199 malignant lesions that were collected and confirmed through clinical pathology or biopsy. The enrolled patients were randomly allocated into two groups: a training cohort and an independent test cohort, maintaining a ratio of 7:3.We created a model called CLDLR that utilizes clinical parameters and DLR to diagnose both BBL and MBL through grayscale ultrasound images. In order to assess the practicality of the CLDLR model, two rounds of evaluations were conducted by radiologists. The CLDLR model demonstrates the highest diagnostic performance in predicting benign and malignant BI-RADS 4 lesions, with areas under the receiver operating characteristic curve (AUC) of 0.988 (95% confidence interval : 0.949, 0.985) in the training cohort and 0.888 (95% confidence interval : 0.829, 0.947) in the testing cohort.The CLDLR model outperformed the diagnoses made by the three radiologists in the initial assessment of the testing cohorts. By utilizing AI scores from the CLDLR model and heatmaps from the DLR model, the diagnostic performance of all radiologists was further enhanced in the testing cohorts. Our study presents a noninvasive imaging biomarker for the prediction of benign and malignant BI-RADS 4 lesions. By comparing the results from two rounds of assessment, our AI-assisted diagnostic tool demonstrates practical value for radiologists with varying levels of experience.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.